U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855537) titled 'Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques' on Jan. 13.
Brief Summary: The aim of this clinical trial is to explore the optimal preventative treatment strategy for non-flow-limiting vulnerable plaques. The main question it aims to answer is:
Can interventional therapy further improve the outcome of non-flow-limiting vulnerable plaques on top of optimal pharmacologic therapy?
Researchers will randomly assign patients who meet the inclusion criteria to preventative intervention plus optimal drug therapy (experimental group) or optimal drug therapy alone (control group).
Participants will:
Assi...